Carey Ng
Director/Board Member bei IMMIX BIOPHARMA, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Carey J.
Ng is currently the Managing Director at Mesa Verde Ventures LLC since 2013.
He is also a Director at Satiogen Pharmaceuticals, Inc., Elysium Therapeutics, Inc., Immix Biopharma, Inc., Paradigm Diagnostics, Inc., and MatriSys Bioscience, Inc. Additionally, he previously worked as a Director at Biscayne Neurotherapeutics, Inc. Dr. Ng holds a doctorate degree from the University of California, Los Angeles, and has obtained MBA degrees from both the University of California San Diego and the University of California.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IMMIX BIOPHARMA, INC.
4,05% | 14.09.2023 | 1 035 221 ( 4,05% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Carey Ng
Unternehmen | Position | Beginn |
---|---|---|
IMMIX BIOPHARMA, INC. | Director/Board Member | 01.11.2019 |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Director/Board Member | - |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Private Equity Investor | 01.01.2008 |
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Paradigm Diagnostics, Inc. develops, manufactures and distributes high throughput microbiological screening tests. It has developed and is currently selling diagnostic tests to the food processing industry that allow them to screen environmental samples for pathogens in- house. The company was founded by Alan D. Olstein in 2001 and is headquartered in St. Paul, MN. | Director/Board Member | - |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Director/Board Member | - |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA. | Director/Board Member | - |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company. | Corporate Officer/Principal | 01.12.2013 |
Ehemalige bekannte Positionen von Carey Ng
Unternehmen | Position | Ende |
---|---|---|
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Biscayne Neurotherapeutics, Inc. engages in the development of novel treatments for epilepsy, pain and other central nervous system (CNS) disorders. The company was founded by Samuel J. Reich on November 15, 2011 and is headquartered in Miami, FL. | Director/Board Member | - |
Ausbildung von Carey Ng
University of California, Los Angeles | Doctorate Degree |
University of California | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IMMIX BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Paradigm Diagnostics, Inc. develops, manufactures and distributes high throughput microbiological screening tests. It has developed and is currently selling diagnostic tests to the food processing industry that allow them to screen environmental samples for pathogens in- house. The company was founded by Alan D. Olstein in 2001 and is headquartered in St. Paul, MN. | Health Technology |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Finance |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Commercial Services |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company. | Finance |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Biscayne Neurotherapeutics, Inc. engages in the development of novel treatments for epilepsy, pain and other central nervous system (CNS) disorders. The company was founded by Samuel J. Reich on November 15, 2011 and is headquartered in Miami, FL. | Health Technology |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA. | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Health Technology |